Serum testosterone and oestradiol predict the growth response during puberty promoting treatment.
Heta HuttunenTero VarimoHanna HuopioRaimo VoutilainenSirpa TenholaPäivi J MiettinenTaneli RaivioMatti HeroPublished in: Clinical endocrinology (2021)
During puberty promoting treatment with testosterone or aromatase inhibitor letrozole, growth response is tightly correlated with serum testosterone level. A threshold level of oestrogen appears to be needed for an optimal growth rate that corresponds to normal male peak height velocity of puberty. Serum testosterone 1 week after the injection and serum testosterone and oestradiol 3 months after the onset of aromatase inhibitor treatment can be used as biomarkers for treatment response in terms of growth.